Literature DB >> 12354883

Use of 16S rRNA gene sequencing for identification of nonfermenting gram-negative bacilli recovered from patients attending a single cystic fibrosis center.

Agnes Ferroni1, Isabelle Sermet-Gaudelus, Eric Abachin, Gilles Quesne, Gerard Lenoir, Patrick Berche, Jean-Louis Gaillard.   

Abstract

During 1999, we used partial 16S rRNA gene sequencing for the prospective identification of atypical nonfermenting gram-negative bacilli isolated from patients attending our cystic fibrosis center. Of 1,093 isolates of nonfermenting gram-negative bacilli recovered from 148 patients, 46 (4.2%) gave problematic results with conventional phenotypic tests. These 46 isolates were genotypically identified as Pseudomonas aeruginosa (19 isolates, 12 patients), Achromobacter xylosoxidans (10 isolates, 8 patients), Stenotrophomonas maltophilia (9 isolates, 9 patients), Burkholderia cepacia genomovar I/III (3 isolates, 3 patients), Burkholderia vietnamiensis (1 isolate), Burkholderia gladioli (1 isolate), and Ralstonia mannitolilytica (3 isolates, 2 patients), a recently recognized species.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12354883      PMCID: PMC130867          DOI: 10.1128/JCM.40.10.3793-3797.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  22 in total

1.  Classification of Ralstonia pickettii biovar 3/'thomasii' strains (Pickett 1994) and of new isolates related to nosocomial recurrent meningitis as Ralstonia mannitolytica sp. nov.

Authors:  T De Baere; S Steyaert; G Wauters; P Des Vos; J Goris; T Coenye; T Suyama; G Verschraegen; M Vaneechoutte
Journal:  Int J Syst Evol Microbiol       Date:  2001-03       Impact factor: 2.747

2.  Phenotypic conversion of Pseudomonas aeruginosa in cystic fibrosis.

Authors:  M Fegan; P Francis; A C Hayward; G H Davis; J A Fuerst
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

3.  Identification and antimicrobial susceptibility of Alcaligenes xylosoxidans isolated from patients with cystic fibrosis.

Authors:  L Saiman; Y Chen; S Tabibi; P San Gabriel; J Zhou; Z Liu; L Lai; S Whittier
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

4.  PCR-based detection and identification of Burkholderia cepacia complex pathogens in sputum from cystic fibrosis patients.

Authors:  A McDowell; E Mahenthiralingam; J E Moore; K E Dunbar; A K Webb; M E Dodd; S L Martin; B C Millar; C J Scott; M Crowe; J S Elborn
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

5.  Identification of Burkholderia species and genomovars from cystic fibrosis patients by AFLP fingerprinting.

Authors:  T Coenye; L M Schouls; J R Govan; K Kersters; P Vandamme
Journal:  Int J Syst Bacteriol       Date:  1999-10

6.  DNA-Based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III.

Authors:  E Mahenthiralingam; J Bischof; S K Byrne; C Radomski; J E Davies; Y Av-Gay; P Vandamme
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

7.  Burkholderia ambifaria sp. nov., a novel member of the Burkholderia cepacia complex including biocontrol and cystic fibrosis-related isolates.

Authors:  T Coenye; E Mahenthiralingam; D Henry; J J LiPuma; S Laevens; M Gillis; D P Speert; P Vandamme
Journal:  Int J Syst Evol Microbiol       Date:  2001-07       Impact factor: 2.747

8.  Misidentification of Burkholderia cepacia in US cystic fibrosis treatment centers: an analysis of 1,051 recent sputum isolates.

Authors:  J D McMenamin; T M Zaccone; T Coenye; P Vandamme; J J LiPuma
Journal:  Chest       Date:  2000-06       Impact factor: 9.410

9.  Utility of commercial systems for identification of Burkholderia cepacia complex from cystic fibrosis sputum culture.

Authors:  D B Shelly; T Spilker; E J Gracely; T Coenye; P Vandamme; J J LiPuma
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

10.  Capillary electrophoresis-single-strand conformation polymorphism analysis for rapid identification of Pseudomonas aeruginosa and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis.

Authors:  R Ghozzi; P Morand; A Ferroni; J L Beretti; E Bingen; C Segonds; M O Husson; D Izard; P Berche; J L Gaillard
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

View more
  30 in total

1.  Comparison of conventional and molecular methods for identification of aerobic catalase-negative gram-positive cocci in the clinical laboratory.

Authors:  P P Bosshard; S Abels; M Altwegg; E C Böttger; R Zbinden
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

2.  Burkholderia gladioli sepsis in newborns.

Authors:  Arzu Dursun; Aysegul Zenciroglu; Belma Saygili Karagol; Nilay Hakan; Nurullah Okumus; Nese Gol; Gonul Tanir
Journal:  Eur J Pediatr       Date:  2012-05-31       Impact factor: 3.183

3.  16S rRNA gene sequencing versus the API 20 NE system and the VITEK 2 ID-GNB card for identification of nonfermenting Gram-negative bacteria in the clinical laboratory.

Authors:  P P Bosshard; R Zbinden; S Abels; B Böddinghaus; M Altwegg; E C Böttger
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

4.  Application of SmartGene IDNS software to partial 16S rRNA gene sequences for a diverse group of bacteria in a clinical laboratory.

Authors:  Keith E Simmon; Ann C Croft; Cathy A Petti
Journal:  J Clin Microbiol       Date:  2006-10-18       Impact factor: 5.948

5.  Identification of isolates within the Burkholderia cepacia complex by a multiplex recA and 16S rRNA gene real-time PCR assay.

Authors:  Jason D Pimentel; Sally M Dubedat; Evan L N Dodds; Richard A V Benn
Journal:  J Clin Microbiol       Date:  2007-09-12       Impact factor: 5.948

6.  Multi-center evaluation of the VITEK® MS system for mass spectrometric identification of non-Enterobacteriaceae Gram-negative bacilli.

Authors:  R Manji; M Bythrow; J A Branda; C-A D Burnham; M J Ferraro; O B Garner; R Jennemann; M A Lewinski; A B Mochon; G W Procop; S S Richter; J A Rychert; L Sercia; L F Westblade; C C Ginocchio
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-09-10       Impact factor: 3.267

7.  True microbiota involved in chronic lung infection of cystic fibrosis patients found by culturing and 16S rRNA gene analysis.

Authors:  Vibeke B Rudkjøbing; Trine R Thomsen; Morten Alhede; Kasper N Kragh; Per H Nielsen; Ulla R Johansen; Michael Givskov; Niels Høiby; Thomas Bjarnsholt
Journal:  J Clin Microbiol       Date:  2011-10-19       Impact factor: 5.948

8.  The rebirth of culture in microbiology through the example of culturomics to study human gut microbiota.

Authors:  Jean-Christophe Lagier; Perrine Hugon; Saber Khelaifia; Pierre-Edouard Fournier; Bernard La Scola; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

9.  Microbiological and epidemiological features of clinical respiratory isolates of Burkholderia gladioli.

Authors:  Christine Segonds; Patricia Clavel-Batut; Michelle Thouverez; Dominique Grenet; Alain Le Coustumier; Patrick Plésiat; Gérard Chabanon
Journal:  J Clin Microbiol       Date:  2009-03-18       Impact factor: 5.948

10.  Use of amplified ribosomal DNA restriction analysis for identification of Ralstonia and Pandoraea species: interest in determination of the respiratory bacterial flora in patients with cystic fibrosis.

Authors:  Christine Segonds; Sandrine Paute; Gérard Chabanon
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.